Loading company…
P95 provides clinical trial and epidemiological research services, with a focus on vaccines and infectious diseases.
P95 is a contract research organization specializing in clinical trials and epidemiological research, particularly for vaccines and infectious diseases. Its services cover clinical trial phases I-IV, from study design and management to safety, data analysis, and medical writing. Founded in 2011, it is based in Leuven, Belgium, and was at Seed stage. In May 2023, Ampersand Capital Partners acquired a majority stake to support growth.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in